Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
AUTOR(ES)
Liu, W G
RESUMO
The effects of 2,2'-O-cyclocytidine (CC) and acyclovir (ACV) on latent herpes simplex virus (HSV) in trigeminal ganglia were studied in an in vitro model using reactivation of HSV type 1 (HSV-1) as a model. It was shown that both CC (10 micrograms/ml) and ACV (2.5 micrograms/ml) significantly inhibited the reactivation of the latent HSV-1 in infected ganglia. The effect of CC (25 micrograms/ml), which was as good as that of ACV (10 micrograms/ml), did not last as long as that of ACV after removal of the drugs. The latent state of HSV-1 in vitro was dependent on the continuous presence of either drug. Even though the latent HSV-1 could not be eliminated completely from the trigeminal ganglia by discontinuous administration of either drug, its titers were markedly reduced. The combination of CC and ACV had a synergistic effect on preventing the reactivation of the latent HSV-1 in vitro.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176390Documentos Relacionados
- Effect of Acyclovir on Latent Herpes Simplex Virus Infections in Trigeminal Ganglia of Mice†
- Effects of Prolonged Cultivation in the Presence of Acyclovir on Recovery of Latent Herpes Simplex Virus from Human Trigeminal Ganglia
- Latent herpes simplex virus type 1 transcription in human trigeminal ganglia.
- Quantitation of Latent Varicella-Zoster Virus and Herpes Simplex Virus Genomes in Human Trigeminal Ganglia
- Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia.
